A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

Krankenhaus der Barmherzigen Brüder Wien ( Site 1041), Vienna

Institut Jules Bordet ( Site 1103), Anderlecht

Medizinische Universität Wien ( Site 1021), Vienna

Klinik Ottakring-1.Medizinische Abteilung - Zentrum für Onkologie und Hämatologie ( Site 1031), Vienna

Cliniques Universitaires Saint Luc - Bruxelles ( Site 1105), Brussels

Hopitaux Universitaires de Geneve HUG ( Site 1602), Geneva

Hospital Británico de Buenos Aires-Oncology ( Site 0801), Ciudad Autónoma de Buenos Aires

Sanatorio Británico-Clinical Oncology Department ( Site 0802), Rosario

GenesisCare North Shore ( Site 4011), St Leonards

Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 4010), Melbourne

UZ Leuven ( Site 1101), Leuven

Peninsula Health Frankston Hospital ( Site 4001), Frankston

CHU de Liege ( Site 1102), Liège

Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 1001), Linz

Lyell McEwin Hospital ( Site 4004), Elizabeth Vale

Grand Hopital de Charleroi ( Site 1104), Charleroi

Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 1604), Bellinzona

Kantonsspital Graubuenden ( Site 1600), Chur

Universitaetsspital Zuerich ( Site 1601), Zurich

Medizinische Universitätsklinik Graz ( Site 1051), Graz

UZ Gent ( Site 1100), Ghent

Ospedale San Luigi Gonzaga ( Site 1405), Orbassano

Memorial Sloan Kettering Cancer Center ( Site 0055), New York

Charite Universitaetsmedizin Berlin ( Site 1321), Berlin

R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0013), Lake Success

HELIOS Klinikum Berlin-Buch ( Site 1311), Berlin

Complejo Hospitalario Universitario A Coruna ( Site 1502), A Coruña

Lehigh Valley Hospital- Cedar Crest-Oncology Clinical Trials ( Site 0056), Allentown

Georgetown University Medical Center ( Site 0006), Washington D.C.

Istituto Clinico Humanitas Research Hospital ( Site 1406), Rozzano

IRCCS Ospedale San Raffaele ( Site 1409), Milan

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1400), Milan

TYKS ( Site 1802), Turku

Blue Ridge Cancer Care - Roanoke ( Site 0043), Roanoke

UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 3302), Pátrai

Istituti Clinici Scientifici Maugeri Spa ( Site 1403), Pavia

Duke Cancer Institute ( Site 0096), Durham

Hospital General Universitario Gregorio Maranon ( Site 1505), Madrid

Hospital Clinico San Carlos ( Site 1504), Madrid

Hospital Universitario 12 de Octubre-Medical Oncology ( Site 1508), Madrid

Levine Cancer Institute ( Site 0004), Charlotte

Emory University Hospital ( Site 0012), Atlanta

University Cancer & Blood Center, LLC ( Site 0057), Athens

Institut Claudius Regaud ( Site 1215), Toulouse

AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlando ( Site 0003), Orlando

Orlando Health, Inc. ( Site 0035), Orlando

CHU de Bordeaux- Hopital Saint Andre ( Site 1209), Bordeaux

Tampereen yliopistollinen sairaala ( Site 1801), Tampere

Ospedale Maggiore Borgo Trento ( Site 1408), Verona

University of Mississippi Medical Ctr ( Site 0037), Jackson

Norton Cancer Institute - St. Matthews ( Site 0065), Louisville

Hospital Virgen del Rocio ( Site 1503), Seville

Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 1201), Saint-Herblain

Parkview Cancer Institute ( Site 0088), Fort Wayne

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 1407), Meldola

Institut de Cancerologie de l Ouest Site Paul Papin ( Site 1200), Angers

Cancer & Hematology Centers of Western Michigan ( Site 0018), Grand Rapids

Institut Jean Godinot ( Site 1216), Reims

Universitaetsklinikum Aachen AOER ( Site 1317), Aachen

Medical Oncology Ospedale San Donato ( Site 1404), Arezzo

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0005), Saint Louis Park

Chonnam National University Hwasun Hospital-Oncology ( Site 4203), Hwasun

Universitaetsklinikum Frankfurt ( Site 1301), Frankfurt am Main

Rush University Medical Center ( Site 0040), Chicago

Illinois Cancer Care, PC ( Site 0008), Peoria

Universitaetsklinikum des Saarlandes ( Site 1305), Homburg/ Saar

Institut de cancérologie Strasbourg Europe (ICANS) ( Site 1218), Strasbourg

Cancer Partners of Nebraska ( Site 0086), Lincoln

NCT-Department of Medical Oncology ( Site 1320), Heidelberg

Tulane University School of Medicine ( Site 0098), New Orleans

Azienda Ospedaliera Policlinico di Bari ( Site 1402), Bari

Hopital Tenon ( Site 1213), Paris

Klinik fuer Urologie ( Site 1303), Freiburg im Breisgau

Ironwood Cancer & Research Centers ( Site 0077), Chandler

Clinique Francois Chenieux ( Site 1210), Limoges

Cedars Sinai Medical Center ( Site 0027), Los Angeles

UCLA Hematology/Oncology - Santa Monica ( Site 0048), Los Angeles

Providence Saint John's Health Center ( Site 0083), Santa Monica

Klinikum Nuernberg Nord ( Site 1300), Nuremberg

St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0095), Orange

UC Irvine Health ( Site 0029), Orange

Seattle Cancer Care Alliance-Renal/Melanoma/MCC ( Site 0093), Seattle

Helios Klinikum Erfurt GmbH ( Site 1315), Erfurt

Instituto Nacional de Cancerología-Clinical Oncology ( Site 0500), Bogotá

FSBI United Hospital with Polyclinic ( Site 2613), Moscow

Hadassah Medical-Oncology department ( Site 2609), Moscow

SHI of Moscow City Oncology Clinical Hospital - 62 ( Site 2614), Moscow

MEDSI Clinical Hospital on Pyatnitsky Highway-Departmentof Antitumor Drug therapy ( Site 2618), Krasnogorsk

Yaroslavl Regional Cancer Hospital-Oncology ( Site 2619), Yaroslavl

Ivanovo Regional Oncology Dispensary ( Site 2616), Ivanovo

Sociedad De Oncologia Y Hematologia Del Cesar-Oncology ( Site 0508), Valledupar

"Centrul de Oncologie Sfântul Nectarie ( Site 2502)", Craiova

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2500), Cluj-Napoca

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2501), Cluj-Napoca

Volgograd Regional Uronephrological Center ( Site 2615), Volzhsky

Fundación Cardiovascular de Colombia ( Site 0501), Piedecuesta

Tokyo Medical and Dental University Hospital ( Site 5009), Bunkyo-ku

Yokohama City University Hospital ( Site 5007), Yokohama

National Cancer Center Hospital East ( Site 5000), Kashiwa

James Lind Centro de Investigación del Cáncer ( Site 0402), Temuco

Bradfordhill-Clinical Area ( Site 0400), Santiago

Liga Norte Riograndense Contra o Cancer ( Site 0313), Natal

Lahey Hospital & Medical Center ( Site 0090), Burlington

Rutgers Cancer Institute of New Jersey ( Site 0078), New Brunswick

University of Texas, Southwestern Medical Center ( Site 0015), Dallas

Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 7001), Salt Lake City

University of Vermont Medical Center ( Site 0001), Burlington

"Confluence Health , Wenatchee Valley Hospital & Clinics ( Site 0061)"

Centro de Urología (CDU) ( Site 0803), CABA

Instituto Alexander Fleming ( Site 0800), Ciudad Autónoma de Buenos Aires

Sanatorio Parque ( Site 0806), Rosario

Asociación de Beneficencia Hospital Sirio Libanés ( Site 0804), Buenos Aires

Centro Gaucho Integrado de Oncologia ( Site 0304), Porto Alegre

BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 0311), São Paulo

Hospital Paulistano - Amil Clinical Research ( Site 0308), São Paulo

Tom Baker Cancer Centre ( Site 0109), Calgary

Cross Cancer Institute ( Site 0111), Edmonton

BC Cancer Vancouver-Clinical Trials Unit ( Site 0110), Vancouver

The Moncton Hospital ( Site 0101), Moncton

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0114), Hamilton

Kingston Health Sciences Centre ( Site 0105), Kingston

The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 0116), Ottawa

Sunnybrook Health Sciences - Odette Cancer Centre ( Site 0113), Toronto

CISSS de la Monteregie-Centre ( Site 0103), Greenfield Park

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Québec

CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0102), Sherbrooke

Fundación Colombiana de Cancerología Clínica Vida ( Site 0505), Medellín

Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 2203), Brno

Nemocnice České Budějovice-Onkologicke oddeleni ( Site 2204), České Budějovice

Fakultni Thomayerova nemocnice-Onkologicka klinika 1. LF UK ( Site 2200), Prague

Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 2205), Prague

Fakultni nemocnice Hradec Kralove-Klinika onkologie a radioterapie ( Site 2201), Hradec Králové

HYKS ( Site 1800), Helsinki

Centre Antoine Lacassagne ( Site 1217), Nice

Krankenhaus Martha Maria Halle-Doelau ( Site 1314), Halle

Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 3304), Athens

Athens Medical Center ( Site 3303), Athens

ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 3301), Chaïdári

European Interbalkan Medical Center-Oncology Department ( Site 3300), Thessaloniki

Mater Misericordiae University Hospital ( Site 3201), Dublin

Tallaght University Hospital ( Site 3200), Dublin

Mater Private Hospital - Dublin ( Site 3202), Dublin

Fondazione Policlinico Universitario Agostino Gemelli-Medical Oncology ( Site 1410), Roma

Azienda Ospedaliera S. Maria di Terni ( Site 1401), Terni

Fujita Health University ( Site 5003), Toyoake

Toho University Sakura Medical Center ( Site 5014), Sakura

Sapporo Medical University Hospital ( Site 5008), Sapporo

Kobe City Medical Center General Hospital ( Site 5017), Kobe

Nara Medical University Hospital ( Site 5002), Kashihara

Kindai University Hospital- Osakasayama Campus-Urology ( Site 5010), Sayama

Osaka University Hospital ( Site 5012), Suita

Hamamatsu University School of Medicine University Hospital ( Site 5004), Hamamatsu

Toranomon Hospital ( Site 5001), Minato-ku

Kyushu University Hospital ( Site 5005), Fukuoka

Niigata University Medical & Dental Hospital ( Site 5013), Niigata

Osaka International Cancer Institute ( Site 5016), Osaka

Nippon Medical School Hospital ( Site 5006), Tokyo

Tokyo Women's Medical University Adachi Medical Center ( Site 5015), Tokyo

Keio university hospital ( Site 5011), Tokyo

Zuyderland Medical Centre-Trialbureau Interne Geneeskunde ( Site 1904), Sittard-Geleen

Amphia Hospital Location Molengracht ( Site 1912), Breda

Antoni van Leeuwenhoek Ziekenhuis ( Site 1901), Amsterdam

Medisch Centrum Leeuwarden ( Site 1905), Leeuwarden

Erasmus MC ( Site 1913), Rotterdam

Franciscus Gasthuis & Vlietland, Locatie Vlietland ( Site 1909), Schiedam

Haga Ziekenhuis locatie Leyweg-Oncology ( Site 1917), The Hague

Universitair Medisch Centrum Utrecht ( Site 1910), Utrecht

Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 2401), Poznan

Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 2402), Bydgoszcz

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - O-Klinika Onkologii Klinicznej ( Site 240, Krakow

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 2400), Warsaw

Asan Medical Center ( Site 4200), Seoul

Samsung Medical Center ( Site 4201), Seoul

Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1507), Barcelona

Hospital Clinic i Provincial ( Site 1500), Barcelona

Hospital Santa Creu i Sant Pau ( Site 1501), Barcelona

Aberdeen Royal Infirmary-Department of Oncology ( Site 3105), Aberdeen

Royal United Hospital Bath England ( Site 3108), Bath

Nottingham University Hospitals NHS Trust. City Hospital Campus ( Site 3106), Nottingham

Southend University Hospital ( Site 3112), Southend

Imperial Healthcare NHS Trust Charing Cross Hospital ( Site 3107), London

Mount Vernon Cancer Centre ( Site 3101), Northwood

Musgrove Park Hospital ( Site 3103), Taunton

Singleton Hospital ( Site 3111), Swansea